PL2035006T3 - Zastosowanie allopurynolu do leczenia erytrodyzestezji dłoniowo-podeszwowej - Google Patents

Zastosowanie allopurynolu do leczenia erytrodyzestezji dłoniowo-podeszwowej

Info

Publication number
PL2035006T3
PL2035006T3 PL07729768T PL07729768T PL2035006T3 PL 2035006 T3 PL2035006 T3 PL 2035006T3 PL 07729768 T PL07729768 T PL 07729768T PL 07729768 T PL07729768 T PL 07729768T PL 2035006 T3 PL2035006 T3 PL 2035006T3
Authority
PL
Poland
Prior art keywords
allopurinol
treatment
plantar erythrodysesthesia
palmar plantar
palmar
Prior art date
Application number
PL07729768T
Other languages
English (en)
Inventor
Yolanda Rodemer
Original Assignee
Nobera Pharma Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06011432A external-priority patent/EP1862166A1/en
Application filed by Nobera Pharma Sl filed Critical Nobera Pharma Sl
Publication of PL2035006T3 publication Critical patent/PL2035006T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL07729768T 2006-06-01 2007-05-31 Zastosowanie allopurynolu do leczenia erytrodyzestezji dłoniowo-podeszwowej PL2035006T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06011432A EP1862166A1 (en) 2006-06-01 2006-06-01 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
EP07107744 2007-05-08
EP07729768A EP2035006B1 (en) 2006-06-01 2007-05-31 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
PCT/EP2007/055367 WO2007138103A1 (en) 2006-06-01 2007-05-31 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia

Publications (1)

Publication Number Publication Date
PL2035006T3 true PL2035006T3 (pl) 2010-07-30

Family

ID=38512579

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07729768T PL2035006T3 (pl) 2006-06-01 2007-05-31 Zastosowanie allopurynolu do leczenia erytrodyzestezji dłoniowo-podeszwowej

Country Status (21)

Country Link
US (3) US7973046B2 (pl)
EP (1) EP2035006B1 (pl)
JP (3) JP5028480B2 (pl)
KR (1) KR101471022B1 (pl)
AT (1) ATE457729T1 (pl)
AU (1) AU2007267069B2 (pl)
CA (1) CA2654270C (pl)
CY (1) CY1110336T1 (pl)
DE (1) DE602007004849D1 (pl)
DK (1) DK2035006T3 (pl)
ES (1) ES2341379T3 (pl)
HR (1) HRP20100210T1 (pl)
IL (1) IL195472A (pl)
MX (1) MX2008015266A (pl)
NZ (1) NZ573248A (pl)
PL (1) PL2035006T3 (pl)
PT (1) PT2035006E (pl)
RS (1) RS51252B (pl)
RU (1) RU2438673C2 (pl)
SI (1) SI2035006T1 (pl)
WO (1) WO2007138103A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2246057A1 (en) * 2009-04-29 2010-11-03 Nobera Pharma, S.L. Use of allopurinol for the treatment of hand foot skin reaction
EP2488642B1 (en) 2009-10-16 2015-03-11 Duke University Compositions and methods for the treatment of drug-induced hand-foot syndrome
EP2368549A1 (en) 2010-03-25 2011-09-28 BioAlliance Pharma Treating hand-foot syndrome and related pathologies using clonidine or its derivatives
JP4983989B2 (ja) * 2010-03-31 2012-07-25 小野薬品工業株式会社 手足症候群の予防および治療剤
EP2554184B1 (en) 2010-03-31 2016-10-26 ONO Pharmaceutical Co., Ltd. Preventive and/or remedy for hand and foot syndrome
JP4761000B1 (ja) * 2010-11-08 2011-08-31 小野薬品工業株式会社 手足症候群の予防および／または治療剤
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
EP2712613B1 (en) * 2012-09-28 2017-02-08 Pharmadab d.o.o. Vitamin K1 and uses thereof
CN108778263A (zh) * 2016-03-28 2018-11-09 维达克制药有限公司 用于局部用药的稳定药物组合物及其用途
WO2019114705A1 (zh) 2017-12-13 2019-06-20 上海小午医药科技有限公司 一种用于预防或治疗与egfr被抑制相关疾病的方法
CN111989095A (zh) 2018-04-16 2020-11-24 上海岸阔医药科技有限公司 预防或治疗肿瘤疗法副作用的方法
RU2722396C2 (ru) * 2018-07-11 2020-05-29 Федеральное государственное бюджетное учреждение дополнительного профессионального образования "Центральная государственная медицинская академия" Управления делами Президента Российской Федерации (ФГБУ ДПО "ЦГМА") Способ лечения пальмарно-плантарной эритродизестезии

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3011A (en) * 1843-03-21 Improvement in water-wheels
ES2037672T3 (es) 1987-02-13 1993-07-01 Pharm-Allergan Gmbh Utilizacion de pteridinas y/o purinas o de un inhibidor de xantinoxidasa para la fabricacion de un medicamento para el tratamiento de enfermedades degenerativas de la retina condicionadas geneticamente.
JPH03106817A (ja) 1989-09-20 1991-05-07 Nippon Kayaku Co Ltd アロプリノール製剤
JPH066700A (ja) 1992-06-22 1994-01-14 Fujitsu General Ltd ハイビジョン受像機
GB9218711D0 (en) 1992-09-04 1992-10-21 Salim Aws S M Skin cancer treatment
AU4974893A (en) 1992-09-04 1994-03-29 Aws Shakir Mustafa Salim Skin treatment compositions containing dimethylsulphone and allopurinol or oxypurinol
JP3106817B2 (ja) 1993-11-02 2000-11-06 富士電機株式会社 漏電遮断器
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US6060083A (en) 1999-04-01 2000-05-09 Topical Technologies, Inc. Topical DMSO treatment for palmar-plantar erythrodysethesia
EP1292265B1 (de) 2000-06-20 2007-03-21 Henkel Kommanditgesellschaft auf Aktien Verwendung von Vitamin B6-Derivaten zur Haarstrukturverbesserung
US6685917B2 (en) 2000-11-22 2004-02-03 Rxkinetix, Inc. Treatment of mucositis
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US20050054991A1 (en) * 2001-08-29 2005-03-10 Tobyn Michael John Topical administration device
CA2466869C (en) 2001-11-29 2010-01-19 Sound Pharmaceuticals Incorporated Methods and compositions for ameliorating the undesirable effects of chemotherapy
DE10200578A1 (de) * 2002-01-09 2003-07-10 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme
US6979688B2 (en) * 2002-02-12 2005-12-27 Ford John P Treatment method against side-effects of chemotherapy
US20040214215A1 (en) * 2003-03-07 2004-10-28 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
WO2004110380A2 (en) 2003-06-11 2004-12-23 Novacea, Inc. Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents
CA2528359A1 (en) 2003-06-11 2004-12-23 Novacea, Inc. Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
US20050148910A1 (en) 2003-12-24 2005-07-07 Gregory Skover Apparatus having a skin-contactable element containing an agent
CA2557814A1 (en) * 2004-03-01 2005-09-15 Lumen Therapeutics, Llc Compositions and methods for treating diseases
JP4405326B2 (ja) 2004-06-28 2010-01-27 株式会社東芝 ランドリー機器
ES2614113T3 (es) * 2004-09-17 2017-05-29 Biomas Ltd. Uso de tricloro (dioxietilen-O,O’) telurato de amonio (AS101) para la inhibición de la enzima convertidora de interleucina-1 beta

Also Published As

Publication number Publication date
WO2007138103A1 (en) 2007-12-06
EP2035006B1 (en) 2010-02-17
NZ573248A (en) 2011-01-28
RU2438673C2 (ru) 2012-01-10
DE602007004849D1 (de) 2010-04-01
JP2009542581A (ja) 2009-12-03
DK2035006T3 (da) 2010-04-19
ES2341379T3 (es) 2010-06-18
KR20090031697A (ko) 2009-03-27
IL195472A0 (en) 2011-08-01
MX2008015266A (es) 2009-02-10
AU2007267069B2 (en) 2011-08-11
SI2035006T1 (sl) 2010-04-30
US7973046B2 (en) 2011-07-05
CA2654270C (en) 2014-05-13
HRP20100210T1 (hr) 2010-05-31
RS51252B (sr) 2010-12-31
KR101471022B1 (ko) 2014-12-09
US8557829B2 (en) 2013-10-15
US20090306097A1 (en) 2009-12-10
ATE457729T1 (de) 2010-03-15
US20110224237A1 (en) 2011-09-15
CA2654270A1 (en) 2007-12-06
JP5389980B2 (ja) 2014-01-15
JP5028480B2 (ja) 2012-09-19
JP2012180370A (ja) 2012-09-20
CY1110336T1 (el) 2015-01-14
EP2035006A1 (en) 2009-03-18
RU2008152341A (ru) 2010-07-20
US20140011820A1 (en) 2014-01-09
JP2014028851A (ja) 2014-02-13
IL195472A (en) 2012-04-30
AU2007267069A1 (en) 2007-12-06
PT2035006E (pt) 2010-04-22

Similar Documents

Publication Publication Date Title
IL195472A0 (en) Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
MY178634A (en) Topical formulation for a jak inhibitor
HK1216506A1 (zh) 含硒組合物及其治療和預防與線粒體功能障礙有關的疾病或病症的應用
MY148688A (en) 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
CL2013001136A1 (es) Un agente inhibitorio de la fosfodiesterasa 7 (pde7) para ser usado en el tratamiento o la reduccion de la posibilidad de una adiccion; y composicion farmaceutica, forma de dosificacion unitaria y kit farmaceutico que incluyen al inhibidor de fosfodiesterasa 7 (pde7) y un agente terapeutico adicional.
MY164730A (en) Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
MX2009004561A (es) Derivados de pirazolilo con actividad analgesica y utiles en el tratamiento o profilaxis del dolor.
SG150531A1 (en) Use of meloxicam for the treatment of respiratory diseases in pigs
WO2008006839A3 (en) Combinations of flibanserin with caffeine, process for their preparation and use thereof as medicaments
WO2012050831A3 (en) Combination treatment for dermatological conditions
TW200722081A (en) New therapeutic combinations for the treatment or prevention of depression
NZ700924A (en) Dosage regimen for a pi-3 kinase inhibitor
MX2011011529A (es) Uso de alopurinol para el tratamiento de la reaccion cutanea en manos-pies.
MX2009005798A (es) Recuperacion de apoplejia.
WO2006102899A3 (en) Oxaprozin or closely related compound for the treatment and prevention of
WO2007144889A3 (en) Treatment of neurofibromatosis
WO2008100653A3 (en) Copper lowering treatment of cardiac disease
ZA201008022B (en) Pharmaceutical compositions for the treatment of warts
UA27836U (en) Method for treating community-acquired pneumonia of group 3 in adult patients
MX2009004627A (es) Uso de inhibidores de dipeptidil-peptidasa iv para prevenir, demorar, o reducir la presentacion de edema.
RU2007107532A (ru) Способ лечения нарушений первичного гемостаза у лиц с метаболическим синдромом
PT1817029E (pt) Derivado isoxazólico para o alívio de dores neuropáticas
HK1171168A1 (zh) 利用拉喹莫德治疗克罗恩病